Cargando…

Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus

The increased prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) is an emerging health care threat. Genome-based comparative methods hold great promise to uncover the genetic basis of the VISA phenotype, which remains obscure. S. aureus isolates were collected from a single individua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rishishwar, Lavanya, Kraft, Colleen S., Jordan, I. King
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954867/ https://www.ncbi.nlm.nih.gov/pubmed/27446992 http://dx.doi.org/10.1128/mSphere.00094-16

Ejemplares similares

Reduced Susceptibility to Vancomycin in Staphylococcus aureus
por: Mimica, Marcelo J.
Publicado: (2011)

Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)

Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings
por: SPAGNOLO, A.M., et al.
Publicado: (2014)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
por: Lin, Chien-Yu, et al.
Publicado: (2018)

Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
por: Ramaraj, Thiruvarangan, et al.
Publicado: (2014)

Evaluating vancomycin susceptibility in Staphylococcus aureus
por: Mimica, Marcelo J, et al.
Publicado: (2016)

Different Antimicrobial Susceptibility Testing Methods to Determine Vancomycin Susceptibility and MIC for Staphylococcus aureus with Reduced Vancomycin Susceptibility
por: Chung, Hae-Sun, et al.
Publicado: (2022)

Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus
por: Sirichoat, Auttawit, et al.
Publicado: (2016)

Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
por: SRİSRATTAKARN, Arpasiri, et al.
Publicado: (2021)

Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro
por: Xu, Jia, et al.
Publicado: (2018)

Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.
por: Rotun, S S, et al.
Publicado: (1999)

2322. Reduced Vancomycin Susceptibility Among Pediatric Staphylococcus aureus Bloodstream Infections
por: Ericson, Jessica, et al.
Publicado: (2018)

136. Factors Associated with Reduced Vancomycin Susceptibility in Pediatric Staphylococcus aureus Bacteremia
por: Ericson, Jessica E, et al.
Publicado: (2019)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

Clinical implications of vancomycin susceptibility testing in Staphylococcus aureus
por: Mimica, Marcelo J.
Publicado: (2013)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
por: Howe, Robin A., et al.
Publicado: (2004)

Vancomycin MIC Distribution among Methicillin-Resistant Staphylococcus Aureus. Is Reduced Vancomycin Susceptibility Related To MIC Creep?
por: Othman, Hala B., et al.
Publicado: (2018)

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
por: Katayama, Yuki, et al.
Publicado: (2016)

Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
por: Peng, Huagang, et al.
Publicado: (2018)

Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA)
por: McCallin, Shawna, et al.
Publicado: (2022)

Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility
por: Jansen, Andrea, et al.
Publicado: (2013)

Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia
por: Ejaz, Mohammad, et al.
Publicado: (2023)

Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC Creep’): implications for therapy
por: Dhand, Abhay, et al.
Publicado: (2012)

The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus
por: Hort, Michael, et al.
Publicado: (2021)

Whole-Genome Sequences of Staphylococcus aureus Isolates from Cystic Fibrosis Lung Infections
por: Bernardy, Eryn E., et al.
Publicado: (2019)

Laboratory Reporting of Staphylococcus aureus with Reduced Susceptibility to Vancomycin in United States Department of Veterans Affairs Facilities
por: Kralovic, Stephen M., et al.
Publicado: (2002)

Vancomycin Resistance in Staphylococcus aureus 
por: McGuinness, Will A., et al.
Publicado: (2017)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Human antimicrobial peptide, LL-37, induces non-inheritable reduced susceptibility to vancomycin in Staphylococcus aureus
por: Friberg, Cathrine, et al.
Publicado: (2020)

Native American admixture recapitulates population-specific migration and settlement of the continental United States
por: Jordan, I. King, et al.
Publicado: (2019)

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
por: Hu, Jian, et al.
Publicado: (2013)

Genomic Analysis of the Emergence of Vancomycin-Resistant Staphylococcus aureus
por: Kobayashi, Scott D., et al.
Publicado: (2012)

1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
por: Saravolatz, Louis D, et al.
Publicado: (2019)

Implications of human evolution and admixture for mitochondrial replacement therapy
por: Rishishwar, Lavanya, et al.
Publicado: (2017)

High Glucose Concentration Promotes Vancomycin-Enhanced Biofilm Formation of Vancomycin-Non-Susceptible Staphylococcus aureus in Diabetic Mice
por: Hsu, Chi-Yu, et al.
Publicado: (2015)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011)

In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides
por: Ribes, S., et al.
Publicado: (2010)

Recent pattern of antibiotic resistance in Staphylococcus aureus clinical isolates in Eastern India and the emergence of reduced susceptibility to vancomycin
por: Mohanty, Srujana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_71lduvs844mdg32806jg5929it